Christina Theodore-Oklota

Dr. Christina Theodore-Oklota is the Vice President of Clinical Outcomes Research at Mahzi Therapeutics where she is focused on conducting research to support of clinical endpoint selection and development in rare neurodevelopmental disorders. She has worked across multiple therapeutic areas of drug development implementing clinical outcome assessments to evaluate the efficacy of new treatments through patient reports and neuropsychological assessments. Dr. Theodore-Oklota is a clinical psychologist with a specialization in pediatrics which she earned at Suffolk University in Boston. Prior to joining the pharmaceutical industry, she was a research fellow at The Warren Alpert Medical School of Brown University and at the Stanford School of Medicine in the clinical treatment and assessment of psychological and cognitive outcomes of pediatric oncology, HIV, and pain patients.

Within drug development, Dr. Theodore-Oklota has specialized in developing novel assessments in rare diseases that accurately and efficiently characterize treatment experience using innovative methods and brief, targeted symptom assessments. Externally, she has been a contributor and panelist at multiple endpoint workshops, including being invited to speak at the Institute of Medicine on how to better define, implement, and assess patient-centered endpoints in pediatric clinical trials. She has published multiple papers and presentations on the qualitative and psychometric validation of symptom instruments and health-related quality of life assessments.